The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

18 Sep 2015 07:00

RNS Number : 4406Z
Adamas Finance Asia Limited
17 September 2015
 



 

 

 

Adamas Finance Asia Limited

 

(AIM: ADAM)

 

("Adamas Finance Asia", "ADAM" or the "Company" or the "Group")

 

Interim Consolidated Results for the six months ended 30 June 2015

 

 

Highlights

 

Consolidated NAV at 30 June 2015 of US$117.5 million (31 December 2014: US$118.9 million)
Consolidated loss per share of US¢0.70 (H1 2014: US¢0.50)
Amendment to Investing Policy to allow investment into funds
Progress on disposal of assets to raise cash for re-investment in income generating assets
Appointment of Edmond de Rothschild as Broker

 

 

Adamas Finance Asia Chairman, John Croft, commented: ¡§The six month period to June 2015 was one of steady progress for the Company. Whilst no new investments were made during the period, steps have been taken where feasible to assist portfolio companies with the objective of exiting our current holdings.

 

¡§The amendment to the Investing Policy approved by shareholders in April enables the Company to invest in funds as well as individual assets, facilitating access to investment opportunities in funds with successful track records of income generation. We anticipate announcing investments in line with this policy in the second half of the year.¡¨

 

 

Enquiries:

 

Adamas Finance Asia Limited

John Croft

 

+44 (0) 1825 830587

Nominated Adviser

W H Ireland Limited

Tim Feather

Liam Gribben

+44 (0) 113 394 6600

Broker

Edmond de Rothschild Securities (UK) Limited

 

+44 (0) 20 7845 5950

John Armstrong-Denby

Hiroshi Funaki

Public Relations Advisers

Ryan Communication (Hong Kong)

Scott McFarlane

 

+852 6297 3801

 

 

 

Chairman's Statement

 

On behalf of the Directors, I am pleased to present the unaudited interim consolidated results of the Company for the six month period ended 30 June 2015.

 

The consolidated loss for the period of US$1.34 million resulted from administrative expenses of US$1.17 million (H1 2014 US$1.98 million), a net write down of the portfolio of US$0.45 million, reflecting some minor changes in the independent valuation of a number of portfolio assets, details of which are provided later in this report, offset by income generated from the portfolio of US$0.28 million.

 

At the AGM in April shareholders approved an amendment to the Company's Investing Policy, allowing investment to be made into funds such as the Greater China Credit Fund (GCCF) and the BRJ China Credit Fund, both of which have a track record of regular cash distributions. As exits are achieved from the existing portfolio, the Board anticipates that resulting cash generated will be deployed into these funds and other direct lending opportunities, thereby increasing the proportion of the portfolio that is income generating. The clear objective of this strategy is to reposition the Company so that it can begin to pay dividends to its shareholders in due course.

 

In April the Company appointed Edmond de Rothschild Securities (UK) Limited ("EdR") as its sole Broker. EdR is a prestigious London adviser which specialises in working with emerging market funds. It is anticipated that by working with EdR, we will be able to increase the profile of the Company with the international investment community.

 

No new investments were made during the period under review, predominantly as a result of the delayed receipt of payments from Global Pharm Holdings Group Inc., as reported in the 2014 Annual Report. However, I am pleased to report that regular payments in settlement of the agreed redemption are being received and the Board anticipates making announcements regarding new investments in due course.

 

Details regarding the status of each of the principal portfolio assets are provided below.

Current portfolio

The principal assets held by the Company are:

Principal Assets

Effective

equity interest

Instrument type

Valuation as at 30 June 2015

US$ million

Changtai Jinhongbang Real Estate Development Co. Ltd

15.00%

Structured equity

51.44

Global Pharm Holdings Group Inc. *

-

Redeemable convertible bond

21.11

Fortel Technology Holdings Limited

33.60%

Structured equity

11.31

Hong Kong Mining Holdings Limited

10.95%

Structured equity

10.26

Meize Energy Industrial Holdings Ltd

7.9%

Redeemable convertible preference shares

6.95

101.07

* As announced on 18 December 2014, the Company agreed the redemption of the redeemable convertible bond in Global Pharm. Further details are set out below and in note 13.

 

Changtai Jinhongbang Real Estate Development Co. Ltd ("CJRE") is the owner of a luxury resort and residential development project in Xiamen, Eastern China. CJRE expects to hold a grand opening of a new release of villas and apartments, which will be ready for sale in the second half of the year.

Global Pharm Holdings Group Inc. ("Global Pharm") is a pharmaceutical company involved in pharmaceuticals, the cultivation of herbs for Traditional Chinese Medicine ("TCM") and TCM processing and distribution. As announced previously, Global Pharm did not meet the original redemption payment plan. However, the company has been making regular monthly payments to offset the amounts owing. To date a total of US$5.4 million has been received, leaving an outstanding balance of US$19.6 million, plus interest.

Fortel Technology Holdings Limited ("Fortel") provides IT services and solutions to Chinese state-owned enterprises ("SOE") and small and medium enterprises primarily in the area of smart card systems and Radio Frequency Identification (RFID) tracking system implementation. The company has also developed an online retail platform distributing branded consumer products for young Chinese females between the ages of 18 and 35. Following delays to a long-planned IPO of Fortel, the management team has been focused on the continuing development of its IT solutions business and e-commerce services. The team continues to prepare for an eventual listing.

Hong Kong Mining Holdings Limited ("HKMH") is a resources company whose primary asset is a large dolomite magnesium limestone mine in the province of Shanxi, China. HKMH submitted its A1 filing to the Hong Kong Stock Exchange in July 2015 and hopes to achieve an IPO in the fourth quarter of 2015. The Company¡¦s interest in HKMH increased from 5.26% to 10.95% as a result of an agreement to extend its put option from December 2014 to December 2015.
Meize Energy Industrial Holdings Ltd ("Meize") is a privately-owned company that designs and manufactures blades for wind turbines. It has a strong order book and design contracts for 2015. The financial position is improving and Meize is currently considering a proposal for listing on the National Equities Exchange and Quotations in China sponsored by China International Capital Corporation in 2016.

China Market View

Recent events in China have been unsettling for many in the investment community, but below the surface it is clear that there are many positive opportunities for the Company in this environment.

 

One consequence of the stock market turmoil is that the Beijing Government is stepping in to limit the number of onshore IPOs to prevent further falls in the stock market. This has the effect of driving companies to the private lending market to fund expansion plans.

 

With non-performing loans likely to rise, state-owned banks in China are expected to become even more cautious about lending to privately owned small to medium sized enterprises (SMEs). Currently, more than 90% of SMEs cannot access mainstream bank financing, leading to significant growth in the shadow banking market. Much of the growth in credit since the global financial crisis has been derived from non-mainstream bank financing.

 

Private debt providers, such as ADAM, are typically more nimble and creative in delivering customised financing solutions to corporates.

 

A balanced investment portfolio should include China, the second largest economy in the world. The performance of China's economy is felt not just locally, but globally. In August, the US and Europe suffered extreme market volatility, as well as the rest of Asia. We expect China's economy to continue to expand and the private lending market is a way to avoid volatility. The key is selecting quality investments in specific industries and companies, as well as optimising the structure of transactions. Having an experienced team on the ground with a focus on the right sectors is critical in delivering stable and attractive returns.

 

With the experience and local presence of our investment manager, Adamas Global Alternative Investment Management Inc., we expect to be able to continue to identify good quality SME lending opportunities and view the macro environment as being positive for the growth of the Company.

 

Conclusion

 

In summary, we have made steady progress with our plan to transform the Company from a private equity investor to one that focuses on income generating assets. I hope to be able to report further progress on this in the second half of the year.

 

 

John Croft

Chairman

 

 

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

Six months ended

Year ended

 

 

Note

30 June

2015

Unaudited

US$'000

30 June 2014

Unaudited

US$'000

31 December

2014

Audited

US$'000

Realised gain on disposal of investments

-

238

238

Fair value changes on financial assets at fair value through profit or loss

(450)

821

1,889

Administrative expenses

(1,171)

(1,978)

(3,330)

Operating loss

(1,621)

(919)

(1,203)

Net finance income

126

181

305

Other income

154

106

353

Loss before taxation

(1,341)

(632)

(545)

Taxation

5

-

-

-

Loss for the period

(1,341)

(632)

(545)

Other comprehensive expense

Currency translation differences

-

(44)

(44)

 

Total comprehensive loss for the period

(1,341)

(676)

(589)

Loss per share

7

Basic

0.70 cents

0.50 cents

0.34 cents

Diluted

0.70 cents

0.45 cents

0.34 cents

The results above relate to continuing operations.

 

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

Note

30 June

2015

Unaudited

US$'000

 

30 June

2014

Unaudited

US$'000

 

31 December

2014

Audited

US$'000

Assets

Unquoted financial assets at fair value through profit or loss

8

113,839

116,217

117,576

Quoted financial assets at fair value through profit or loss

9

-

-

-

Loans and other receivables

3,587

3,074

3,380

Cash and cash equivalents

2,740

1,095

492

Total assets

120,166

120,386

121,448

Liabilities

Loan payables and interest payables

2,411

2,408

2,411

Other payables and accruals

228

1,381

184

Total liabilities

2,639

3,789

2,595

Net assets

117,527

116,597

118,853

Equity and reserves

Share capital

10

129,543

127,313

129,528

Share based payment reserve

42

88

42

Accumulated losses

(12,058)

(10,804)

(10,717)

Total equity and reserves attributable to owners of the parent

117,527

116,597

118,853

 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

Share

capital

US$'000

Share

based

payment

reserve

US$'000

Foreign

translation

reserve

US$'000

(Accumulated losses)/

Retained

earnings

US$'000

Total

US$'000

Group balance at 1 January 2014

35,572

31

44

(10,172)

25,475

Loss for the period

-

-

-

(632)

(632)

Other comprehensive expense

Exchange differences arising on translation of foreign operations

-

-

(44)

-

(44)

Total comprehensive expense for the period

-

-

(44)

(632)

(676)

Issue of shares

91,741

-

-

-

91,741

Share-based payments

-

57

-

-

57

Group balance at 30 June 2014

127,313

88

-

(10,804)

116,597

Profit for the period

-

-

-

87

87

Other comprehensive income

Total comprehensive income for the period

-

-

-

87

87

Issue of shares

2,215

-

-

-

2,215

Share-based payments

-

(46)

-

-

(46)

Group balance at 31 December 2014

129,528

42

-

(10,717)

118,853

Loss for the period

-

-

-

(1,341)

(1,341)

Other comprehensive expense

Total comprehensive expense for the period

-

-

-

(1,341)

(1,341)

Issue of shares

15

-

-

-

15

Group balance at 30 June 2015

129,543

42

-

(12,058)

117,527

 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

 

Six months ended

Year ended

30 June

2015

Unaudited

US$'000

30 June

2014

Unaudited

US$'000

31 December

2014

Audited

US$'000

Cash flow from operating activities

Loss before taxation

(1,341)

(632)

(545)

Adjustments for:

Depreciation

-

19

19

Dividend Income

(154)

(80)

(324)

Net finance income

(126)

(181)

(305)

Loss on fixed asset disposal

-

56

56

Fair value changes on unquoted financial assets at fair value through profit or loss

450

(858)

(1,965)

Fair value changes on quoted financial assets at fair value through profit or loss

-

37

76

Realised gain on disposal of investment

-

(238)

(238)

Share-based expenses

-

57

11

Decrease in other receivables

61

169

38

Increase / (decrease) in other payables and accruals

44

572

(625)

Net cash used in operating activities

(1,066)

(1,079)

(3,802)

Cash flow from investing activities

Dividend received

120

75

275

Net finance income received

(108)

-

(108)

Share proceeds of quoted financial assets at fair value through profit or loss

-

885

846

Purchase of unquoted financial assets at fair value through profit and loss

-

(4,287)

(4,436)

Loans granted

(653)

(2,939)

(2,938)

Disposal of investment in Global Pharm

3,940

-

-

Net cash generated from / (used in) investing activities

3,299

(6,266)

(6,361)

Cash flows from financing activities

Loans borrowed

-

2,400

2,400

Net proceeds from issue of shares

15

5,016

7,231

Net cash generated from financing activity

15

7,416

9,631

Net increase / (decrease) in cash & cash equivalents during the period

2,248

71

(532)

Cash & cash equivalents at the beginning of the period

492

1,024

1,024

Cash & cash equivalents at the end of the period

2,740

1,095

492

 

Notes to the financial information

 

1. CORPORATE INFORMATION

 

The Company is a limited company incorporated in the British Virgin Islands ('BVI') under the BVI Business Companies Act 2004 on 18 January 2008. The address of the registered office is Commerce House, Wickhams Cay 1, P.O. Box 3140, Road Town, Tortola, British Virgin Islands VG 1110 and its principal place of business is 1810, 18/F, Tai Yau Building, 181 Johnston Road, Wanchai, Hong Kong.

 

The Company is quoted on the AIM Market of the London Stock Exchange (code: ADAM); and with effect from 6 December 2012, the Company¡¦s ordinary shares have been included on the Quotation Board of the Open Market of the Frankfurt Stock Exchange (code: 1CP1).

 

The principal activity of the Company is investment holding. The Group is principally engaged in investing primarily in unlisted assets in the areas of luxury resorts real estate, pharmaceutical, mining, power generation, telecommunications, media and technology ('TMT') as well as financial services or listed assets driven by corporate events such as mergers and acquisitions, pre-IPO, or re-structuring of state-owned assets.

 

The condensed consolidated interim financial information was approved for issue on 17 September 2015.

 

2. BASIS OF PREPARATION

 

The condensed consolidated interim financial information has been prepared in accordance with International Accounting Standard ('IAS') 34 "Interim Financial Reporting".

 

3. PRINCIPAL ACCOUNTING POLICIES

 

The condensed consolidated interim financial information has been prepared on the historical cost convention, as modified by revaluation of certain financial assets and financial liabilities at fair value through the income statement.

 

The accounting policies and methods of computation used in the condensed consolidated financial information for the six months ended 30 June 2015 are the same as those followed in the preparation of the Group¡¦s annual financial statements for the year ended 31 December 2014 and are those the Group expects to apply into financial statements for the year ending 31 December 2015.

 

The seasonality or cyclicality of operations does not impact on the interim financial information.

 

4. SEGMENT INFORMATION 

 

The operating segment has been determined and reviewed by the Board to be used to make strategic decisions. The Board considers there to be a single business segment, being that of investing activity, which is reportable in two cash generating units.

 

The reportable operating segment derives its revenue primarily from debt investment in several companies and unquoted investments.

 

The Board assesses the performance of the operating segments based on a measure of adjusted Earnings Before Interest, Taxes, Depreciation and Amortisation ("EBITDA"). This measurement basis excludes the effects of non-recurring expenditure from the operating segments such as restructuring costs. The measure also excludes the effects of equity-settled share-based payments and unrealised gains/losses on financial instruments.

 

 

The segment information provided to the Board for the reportable segments for the periods are as follows:

 

Revenue attributed by reference to each company's country of domicile:

 

BVI

Hong Kong

Six months ended

Year ended

Six months ended

Year ended

30 June

2015

30 June

2014

31 December

2014

30 June

2015

30 June

2014

31 December

2014

US$000

US$000

US$000

US$000

US$000

US$000

Realised gain on disposal of investments

-

-

-

-

238

238

Fair value changes on financial assets at fair value through profit or loss

(450)

858

1,925

-

(37)

(36)

Net financial income

126

189

424

-

-

-

Dividend income

154

80

324

-

-

-

Other income

-

3

3

-

23

26

 

5. TAXATION

 

No charge to taxation arises for the six months ended 30 June 2015 and 2014 as there were no taxable profits in either period.

 

Tax reconciliation:

 

Six months ended

Year ended

30 June 2015

US'000

30 June

2014

US'000

31 December

2014

US'000

Loss before taxation

(1,341)

(632)

(545)

Effective tax charge at 16.5% (2014:16.5%)

(221)

(104)

(90)

Effect of:

Differences in overseas taxation rates

221

104

90

Effective tax rate

-

-

-

As at 30 June 2015, the Group has no unused tax losses (30 June 2014: Nil) available for offset against future profits.

 

6. DIVIDEND

 

The Board of the Company does not recommend the payment of an interim dividend in respect of the six months ended 30 June 2015 (30 June 2014: Nil).

 

7. LOSS PER SHARE

 

The calculation of the basic and diluted loss per share attributable to owners of the Group is based on the following:

 

Six months ended

Year ended

30 June 2015

 US'000

30 June 2014

US'000

31 December

2014

US'000

Numerator

Basic / Diluted:

Net loss

(1,341)

(632)

(545)

Number of shares

'000

'000

'000

Denominator

Basic:

Weighted average shares

191,959

127,207

159,663

Effect of diluted securities:

Share options

225

225

225

Warrant

-

13,621

465

Diluted:

Adjusted weighted average shares

192,184

141,053

160,353

 

For the six months ended 30 June 2015 and 2014, the share options are anti-dilutive and therefore the weighted average shares in issue are 191,959,181 and 140,827,552 respectively.

 

The earnings per share calculation for the period to 30 June 2014 is restated from a loss of US¢ 0.05 for basic loss per share and US¢ 0.04 for diluted loss per share to US¢ 0.50 and US¢ 0.45 respectively to reflect the share consolidation on 11 July 2014. In which a reorganisation of the existing ordinary shares was proposed whereby every 10 existing ordinary shares, whether issued or unissued, was consolidated into one new ordinary share.

 

 

8. UNQUOTED FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS

 

30 June

2015

US$'000

30 June

2014

US$'000

31 December

2014

US$'000

At the beginning of the period

117,576

22,637

22,637

Fair value changes through profit and loss

(450)

858

1,965

Addition

653

92,722

92,974

Disposals

(3,940)

-

-

At the end of the period

113,839

116,217

117,576

 

 

9. QUOTED FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS

 

30 June

2015

US$'000

30 June

2014

US$'000

31 December

2014

US$'000

Market value at the beginning of the period

-

684

684

Profit on disposal during the period

-

-

238

Amounts realised during the period

-

(647)

(846)

Decrease in fair value recognised in profit or loss

-

(37)

(76)

Balance at the end of the period

-

-

-

As at 30 June 2015, the Group has no quoted financial assets at fair value through profit or loss (30 June 2014: Nil) were pledged under a securities margin account.

 

10. SHARE CAPITAL

 

Number of

Shares

Amount

US$¡¦000

Authorised, called-up and fully paid ordinary shares of no par value each at 31 December 2014

191,942,420

129,528

Ordinary shares issued for cash on 18 February 2015

24,664

15

Authorised, called-up and fully paid ordinary shares of no par value each at 30 June 2015

191,967,084

129,543

 

 

On 18 February 2015, the Directors issued and allotted 24,664 new ordinary shares of no par value each for consideration of US$14,798 in respect of exercise notices of warrant received at a price of US$0.60 each.

 

Under the BVI corporate laws and regulations, there is no concept of ¡§share premium¡¨, and all proceeds from the sale of no par value equity shares is deemed to be share capital of the Company.

 

 

11. FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS

 

The following table provides an analysis of financial instruments that are measured subsequent to initial recognition at fair value, grouped into Level 1, 2 or 3 based on the degree to which the fair value is observable:

 

l Level 1 fair value measurements are those derived from quoted prices (unadjusted) in active markets for identical assets or liabilities;

 

l Level 2 fair value measurements are those derived from inputs other than quoted prices included within Level 1 that are observable for the assets or liability, either directly or indirectly; and

 

l Level 3 fair value measurements are those derived from inputs that are not based on observable market data.

 

 

 

 

 

As at

30 June 2015

US'000

As at

30 June

2014

US'000

As at

31 December

2014

US'000

Level 3

Unquoted financial assets at fair value through profit or loss (note 8)

113,839

116,217

117,576

113,839

116,217

117,576

 

There is no transfer between levels in the current period. Carrying values of all financial assets and liabilities are approximate to fair values. The value of level 3 investments has been determined using the yield capitalisation (discounted cash flow) method.

 

12. RELATED PARTY TRANSACTIONS

 

During the period under review, the Group entered into the following transactions with related parties and connected parties:

 

Note

30 June

 2015

US$'000

30 June

 2014

US$'000

31 December

 2014

US$'000

Amount due to Directors

(i)

- Conor MacNamara

4

25

4

- Ernest Wong Yiu Kit

2

13

4

- John Croft

9

51

8

Amount due from

Adamas Global Alternative Investment Management Inc.

4

-

16

Period-end balance arising from sales/ purchases of services

Management fee to Investment Manager

(ii)

787

427

1,106

Loan from related party

(iii)

As 1 January

2,411

-

-

Loans borrowed

-

2,400

2,400

Interest charged

108

8

119

Interest paid

(108)

-

(108)

As end of period

2,411

2,408

2,411

 

(i) The amounts due thereto are unsecured, interest free and have no fixed term of repayment. There are no other contracts of significance in which any director has or had a material interest during the current period.

 

(ii) Adamas Global Alternative Investment Management Inc. is the Investment Manager of the Group. The management fee which is calculated and paid bi-annually in advance calculated at an annual rate of 1% of the higher of the net asset value of the Company's portfolio of assets or market capitalisation.

 

(iii) As at 30 June 2015, loan payables and interest payables predominantly represent principal loan amount and interest due to Elypsis Solution Limited ('Elypsis'). The amount due to Elypsis is interest bearing at 9% per annum.

 

 

 

 

13. EVENTS AFTER THE REPORTING PERIOD

 

Disposal of interest in Global Pharm

Under the redemption agreement announced on 18 December 2014, the Company was due to receive an initial payment of US$2.4 million on 31 December 2014, a further US$9 million on 31 March 2015 and a final payment of US$13.6 million on 30 April 2015, an aggregate of US$25 million. The initial payment was received, but the second and third payments were not made in accordance with the agreement. The Company has now received four payments of US$0.75 million which have been offset against the US$9 million which was due on 31 March 2015. Overdue amounts from the two payments due on 31 March 2015 and 30 April 2015 are subject to penalty interest of 26% per annum, compounded on a daily basis. The Company¡¦s Investment Manager, Adamas Global Alternative Investment Management Inc., remains in discussions with Global Pharm to resolve the matter and agree a revised redemption schedule. 

 

 

14. COPIES OF THE INTERIM REPORT

 

The interim report is available for download from www.adamasfinance.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR GMGMLVNVGKZM
Date   Source Headline
13th Jan 20215:23 pmRNSSEDOL Code Update
13th Jan 20217:00 amRNSConfirmation of Change of Company Name
11th Jan 20215:17 pmRNSDirector Dealings
31st Dec 202011:00 amRNSPlacing Update
14th Dec 20208:08 amRNSChange of Auditor
10th Dec 202010:17 amRNSAppointment of new Broker
1st Dec 202011:52 amRNSDirectors Dealings
19th Nov 20207:00 amRNSUnaudited NAV and Portfolio Update for Q3 30 Sept
2nd Nov 202012:21 pmRNSPlacing Update
16th Oct 20203:57 pmRNSHolding(s) in Company
16th Oct 20203:57 pmRNSHolding(s) in Company
16th Oct 20203:55 pmRNSHolding(s) in Company
16th Oct 20203:53 pmRNSHolding(s) in Company
9th Oct 20202:49 pmRNSHolding(s) in Company
7th Oct 20207:00 amRNSResult of Open Offer & Placing & Share Allotment
1st Oct 20207:00 amRNSOpen Offer and Placing Update and Portfolio Update
22nd Sep 20202:12 pmRNSShare Buyback
18th Sep 20204:14 pmRNSOpen Offer and Placing Update
10th Sep 20205:23 pmRNSOpen Offer and Placing Update
7th Sep 20203:10 pmRNSShare Buyback
7th Sep 20207:00 amRNSOpen Offer and Placing Update
2nd Sep 20203:32 pmRNSOpen Offer and Placing Update
28th Aug 20207:00 amRNSAsset Overview: FLMH
24th Aug 20207:00 amRNSResult of Open Offer
21st Aug 20208:50 amRNSInterim Results for the six months ended 30 Jun 20
20th Aug 20201:39 pmRNSHolding(s) in Company
20th Aug 20201:38 pmRNSHolding(s) in Company
19th Aug 20207:00 amRNSAppointment of Non-Executive Director
18th Aug 20208:51 amRNSShare Buyback Programme
17th Aug 20207:22 amRNSResult of 2020 AGM
17th Aug 20207:20 amRNSResult of 2019 AGM
12th Aug 20208:26 amRNSAsset Overview: Meize Energy
7th Aug 20207:00 amRNSUpdate on Future Metal Holdings
5th Aug 20203:07 pmRNSResult of General Meeting
5th Aug 20207:00 amRNSFuture Metal Holdings Limited: Asset Overview
22nd Jul 20207:00 amRNSNotice of 2019 and 2020 Annual General Meetings
20th Jul 202010:26 amRNSHolding(s) in Company
17th Jul 20207:00 amRNSOpen Offer, Placing and Notice of GM
3rd Jul 20209:09 amRNSUpdate on Future Metal Holdings Limited
9th Jun 20204:00 pmRNSAGM Update
3rd Jun 20207:00 amRNSUnaudited Net Asset Value and Portfolio Update
1st Jun 20207:58 amRNSResearch Note and Interview Published
18th May 20207:00 amRNSFinal Results
11th May 20207:00 amRNSSecond Subscription to Corporate Bond
3rd Mar 20202:09 pmRNSPlacing of Shares with a Syndicate
5th Feb 20207:00 amRNSResearch Note and Interview Published
27th Dec 20197:00 amRNSFuture Metal: Production Commenced and Update
23rd Dec 20197:00 amRNSShare Buyback
15th Nov 20197:00 amRNSCompletion of SPA with Infinity Capital Group
14th Nov 20196:24 pmRNSPostponement of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.